ArticleBMC pulmonary medicine2026
Prevalence and risk factors of lung nodules in a non-smoking Chinese population: a prospective study of low-dose computed tomography screening.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundLow-dose computed tomography (LDCT) has significantly improved early detection of lung cancer, especially among high-risk populations. However, the risk factors and lung nodule distributions in non-smoking populations remain underexplored, particularly in Asia. Therefore, in this study, we aimed to explore the risk factors and delineate the detection rate, including lung nodule distributions discovered using LDCT, in a non-smoking Chinese population.
methodsThis prospective, single-center study included asymptomatic adults who underwent LDCT screening at the National Cancer Center of China between January 2006 and December 2023. Lung nodules were defined as at least one non-calcified nodule, while clinically relevant lung nodules were defined as at least one solid or partially solid nodule, or at least one non-solid nodule. Multivariate logistic regression models were employed to identify risk factors associated with lung nodules. The outcomes included detection rates and distribution of both nodule types.
resultsOf 23,271 participants, lung nodules were detected in 40.1% (9,342/23,271); 4.4% (1,023/23,271) had clinically relevant lung nodules. Risk factors for lung nodule development included female sex (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.06-1.19), SHS exposure (OR 1.59, 95% CI 1.49-1.70), and emphysema (OR 1.49, 95% CI 1.24-1.78). The incidence of lung nodules increased with age, peaking at 70-74 years (OR 3.10, 95% CI 2.53-3.79). Risk factors for clinically relevant lung nodules included increasing age, SHS exposure (OR 1.44, 95% CI 1.22-1.69), and emphysema (OR 1.84, 95% CI 1.36-2.49). Detection rates for both nodule types were positively correlated with age (lung nodules: women 33.7-61.4%, men 32.3-57.5%; clinically relevant lung nodules: women 2.4-12.4%, men 2.2-15.1%).
conclusionsThis real-world study of a non-smoking Chinese population revealed high lung nodule detection rates, with women exhibiting a higher detection rate than men. SHS has emerged as a significant risk factor for both lung and clinically relevant nodules. These findings highlight the importance of refining LDCT screening strategies and risk models for non-smoking populations in Asia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.